Press Release

DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)

In Waves and War: Healing Trauma Through the Science of Neuroplasticity

DemeRx Awarded $1.7 Million National Institutes of Health Grant

DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors

DemeRx Joins Medical Psychedelics Working Group to Advance Next-Generation Addiction Treatments

DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment